» Articles » PMID: 19727602

Nitric Oxide and Pathogenic Mechanisms Involved in the Development of Vascular Diseases

Overview
Journal Arch Pharm Res
Specialty Pharmacology
Date 2009 Sep 4
PMID 19727602
Citations 96
Authors
Affiliations
Soon will be listed here.
Abstract

Nitric oxide (NO) is a pivotal signaling messenger in the cardiovascular system. NO participates in regulatory functions including control of hemostasis, fibrinolysis, platelet and leukocyte interactions with the arterial wall, regulation of vascular tone, proliferation of vascular smooth muscle cells, and homeostasis of blood pressure. Diminished NO bioavailability and abnormalities in NO-dependent signaling are among central factors of vascular disease, although it is unclear whether this is a cause of, or result of endothelial dysfunction or both pathogenic events. Disturbances in NO bioavailability have been linked to cause endothelial dysfunction, leading to increased susceptibility to atherosclerotic lesion progression, hypertension, hypercholesterolemia, diabetes mellitus, thrombosis and stroke.

Citing Articles

Regulatory effects of resveratrol on nitric oxide signaling in cardiovascular diseases.

Abolfazli S, Karav S, Johnston T, Sahebkar A Pharmacol Rep. 2025; .

PMID: 39832074 DOI: 10.1007/s43440-025-00694-w.


The NITRATE-OCT study-inorganic nitrate reduces in-stent restenosis in patients with stable coronary artery disease: a double-blind, randomised controlled trial.

Rathod K, Mathur A, Shabbir A, Khambata R, Lau C, Beirne A EClinicalMedicine. 2024; 77:102885.

PMID: 39469537 PMC: 11513660. DOI: 10.1016/j.eclinm.2024.102885.


Arterial Hypertension: Novel Pharmacological Targets and Future Perspectives.

Popa I, Clim A, Pinzariu A, Lazar C, Popa S, Tudorancea I J Clin Med. 2024; 13(19).

PMID: 39407987 PMC: 11478071. DOI: 10.3390/jcm13195927.


Impact of Mouthwash-Induced Oral Microbiome Disruption on Alzheimer's Disease Risk: A Perspective Review.

Boulares A, Jdidi H, Bragazzi N Int Dent J. 2024; 75(1):45-50.

PMID: 39379282 PMC: 11806309. DOI: 10.1016/j.identj.2024.07.005.


Hypoxia-induced NOS1 as a therapeutic target in hypercholesterolemia-related colorectal cancer.

Qiu W, Zhao L, Liu H, Xu P, Qian C Cancer Metab. 2024; 12(1):14.

PMID: 38755702 PMC: 11100240. DOI: 10.1186/s40170-024-00338-2.